Publications list | EBMT

Top

Area

Group

Year

Disease

Text

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases

Autoimmune Diseases Working Party (ADWP)

Infectious Diseases Working Party (IDWP)

1st listed author

Raffaella Greco

Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

Infectious Diseases Working Party (IDWP)

1st listed author

Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation

Autoimmune Diseases Working Party (ADWP)

1st listed author

Alessandro Bruno

J Allergy Clin Immunol.

Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Acute Leukemia Working Party (ALWP)

Global Committee

1st listed author

J Hematol Oncol.

Activity of ex vivo graft and DLI Engineering within the last decade increases, a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Cellular Therapy & Immunobiology Working Party (CTIWP)

1st listed author

Bone Marrow Transplant.

Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)

Acute Leukemia Working Party (ALWP)

Severe Aplastic Anaemia Working Party (SAAWP)

Autoimmune Diseases Working Party (ADWP)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Inborn Errors Working Party (IEWP)

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Lymphoma Working Party (LWP)

Paediatric Diseases Working Party (PDWP)

JACIE Committee

1st listed author

Riccardo Saccardi

Bone Marrow Transplant.

Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

Activity survey office

1st listed author

Jakob R Passweg

Bone Marrow Transplant.

Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas

Lymphoma Working Party (LWP)

1st listed author

Alberto Mussetti

Transplant Cell Ther.

Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study

Infectious Diseases Working Party (IDWP)

1st listed author

Bone Marrow Transplant.

Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Acute Leukemia Working Party (ALWP)

1st listed author

Bone Marrow Transplant.

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party

Cellular Therapy & Immunobiology Working Party (CTIWP)

1st listed author

Raffaella Greco

Bone Marrow Transplant.